References
- Freeman EW, Sondheimer SJ. Premenstrual dysphoric disorder: Recognition and treatment. Prim Care Companion J Clin Psychiatry. 2003;5:30–39.
- Halbreich U. The diagnosis of premenstrual syndromes and premenstrual dysphoric disorder-clinical procedures and research prospectives. Gynaecol Endocrinol. 2004;19:320–334.
- Steiner M, Streiner DL, Steinberg S, et al. The measurement of premenstrual mood symptoms. J Affect Disord. 1999;53:269–273.
- Freeman EW, Sondheimer SJ. Premenstrual dysphoric disorder: recognition and treatment. Prim Care Companion J Clin Psychiatry. 2003;5:30–39.
- Halbreich U. The diagnosis of premenstrual syndromes and premenstrual dysphoric disorder – clinical procedures and research prospectives. Gynecol Endocrinol. 2004;19:320–334.
- Baker LJ, O’Brien PMS. Premenstrual syndrome (PMS): a peri- menopausal perspective. Maturitas. 2012;72:121–125.
- Dennerstein L, Lehert P, Keung LS, Pal SA, Choi D. A population- based survey of Asian women’s experience of premenstrual symptoms. Menopause Int. 2010;16:139–145.
- O’Brien PMS, Bäckström T, Brown C, et al. Towards a consensus on diagnostic criteria, measurement and trial design of the premenstrual disorders: the ISPMD Montreal consensus. Arch Womens Ment Health. 2011;14;13–21.
- American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington DC: American Psychiatric Association; 1994.
- Halbreich U, Backstrom T, Eriksson et al. Clinical diagnostic criteria for premenstrual syndrome and guidelines for their quantification for research studies. Gynaecol Endocrinol. 2007;23:123–130.
- World Health Organization (WHO). International Statistical Classification of Diseases and Related Health Problems, 10th revision. N94.3 Premenstrual Tension syndrome. 2nd ed. Geneva: WHO; 2007.
- Pearlstein T. Prevalence, impact, on morbidity and burdern of disease. In: O’Brien PMS, Rapkin A, Schmidt P, editors. The Premenstrual Syndromes: PMS and PMDD. London: Informa Healthcare; 2007:37–47.
- O’Brien PMS, Backstrom T, Brown C, et al. Towards a consensus on diagnostic criteria, measurement and trial design of premenstrual disorders: the ISPMD Montreal consensus. Arch Womens Mental Health. 2011;14:13–21.
- Weisz G, Knaapen L. Diagnosing and treating premenstrual syndrome in five western nations. Social Sci Med. 2009;68:1498–1505.
- Tschuidin S, Bertea PC, Zemp E. Prevalence and predictors of premenstrual syndrome and premenstrual dysphoric disorder in a population based sample. Arch Womens Mental Health. 2010;13:485–494.
- Takeda T, Tasaka K, Sakata M, Murata Y. Prevalence of premenstrual syndrome and premenstrual dysphoric disorder in Japanese women. Arch Womens Mental Health. 2006;9:209–212.
- Duenas Jl, Lete I, Bermejo, et al. Prevalence of premenstrual syndrome and premenstrual dysphoric disorder in a representative cohort of Spanish women of fertile age. Eur J Obstet Gynaecol Reprod Biol. 2011;156:72–77.
- Duester PA, Adera T, South-Paul J. Biological, social and behavioural factors associated with premenstrual syndrome. Arch Fam Med. 1999;8:122–128.
- Qiao M, Zhang H, Liu H, et al. Prevalence of premenstrual syndrome and premenstrual dysphoric disorder in a population based sample in China. Eur J Obstet Gynaecol Reprod Biol. 2012;162:83–86.
- Ericksen KP. Menstrual symptoms and menstrual beliefs: national and cross national patterns. In: Ginsberg BE, Carter BF, editors. PMS: Ethical and Legal Implications in a Biomedical Perspective. New York: Plenium; 1987:175–188.
- Yonkers KA, O’Brien PMS, Eriksson E. Premenstrual syndrome. Lancet. 2008;371;1200–1210.
- Rubinow DR, Hoban MC, Grover GN, et al. Changes in plasma hormones across the menstrual cycle in patients with menstrually related mood disorder and in control subjects. Am J Obstet Gynecol. 1988;158:5–11.
- Huo L, Straub RE, Roca C, et al. Risk for premenstrual dysphoric disorder is associated with genetic variation ESR1, the estrogen receptor alpha gene. Biol Psychiatry. 2007;62:925–933.
- Royal College of Obstetricians and Gynaecologists. Premenstrual Syndrome, Management (Green-top 48). London: Royal College of Obstetricians and Gynaecologists; 2007. Available from: http://www.rcog.org.uk/files/rcog-corp/uploaded-files/GT48ManagementPremens turalSyndrome.pdf. Accessed August 26, 2013.
- Horrobin DF. The role of essential fatty acids and prostaglandins in the premenstrual syndrome. J Reprod Med. 1983;28:465–468.
- Giugliano D, Torella R. Prostaglandin E1 inhibits glucose-induced insulin secretion in man. Prostaglandins Med. 1978;1:165–166.
- Wyatt KM, Dimmock PW, Frischer M, et al. Prescribing patterns in premenstrual syndrome. BMC Womens Health. 2002;2(1):4.
- Barnes J, Ernst E. Traditional herbalists’ prescriptions for common clinical conditions: a survey of members of the UK National Institute of Medical Herbalists. Phytother Res. 1998;12:369–371.
- Deutch B. Menstrual pain in Danish women correlated with low n-3 polyunsaturated fatty acid intake. Eur J Clin Nutr. 1995;49:508–516.
- Deutch B. Painful menstruation and low intake of n-3 fatty acids. Ugeskr Laeger. 1996;158:4195–4198. Danish.
- Harel Z, Biro FM, Kottenhahn RK, Rosenthal SL. Supplementation with omega-3 polyunsaturated fatty acids in the management of dysmenorrhea in adolescents. Am J Obstet Gynecol. 1996;174:1335–1338.
- Sampalis F, Bunea R, Pelland MF, et al. Evaluation of the effects of Neptune Krill Oil on the management of premenstrual syndrome and dysmenorrhea. Altern Med Rev. 2033;8:171–179.
- Sohrabia N, Kashaniana M, Ghafooria SS, et al. Evaluation of the effect of omega-3 fatty acids in the treatment of premenstrual syndrome: “a pilot trial”. ComplementTher Med. 2013;21;141–146.
- Chocano_bedoya P, Manson JE, Hankinson SE, et al. Dietary B vitamin intake and incident premenstrual syndrome. Am J Clin Nutr. 2011;93: 1080–1086.
- Panay N. Management of premenstrual syndrome: evidence-based guidelines. Obstet Gynecol Reprod Med. 2011;21:221–228.
- Dennehy CE. The use of herbs and dietary supplements in gynecology: an evidence based review. J Midwifery Womens Health. 2006;51: 402–406.
- Kim HW, Kwon MK, Kim NS, Reame NE. Intake of dietary soy isoflavones in relation to perimenstrual symptoms of Korean women living in the USA. Nurs Health Sci. 2006;8:108–113.
- Cassidy A, Bingham S, Setchell KD. Biological effects of a diet of soy protein rich in isoflavones on the menstrual cycle of premenopausal women. Am J Clin Nutr. 1994;60:333–340.
- Bryant M, Cassidy A, Hill C, et al. Effect of consumption of soy isoflavones on behavioural, somatic and affective symptoms in women with premenstrual syndrome. Br J Nutr. 2005;93:731–739.
- Taher S, Cahill A, Eliahoo J, et al. Randomised placebo controlled pilot study on comparing isoflavones versus placebo for the treatment of premenstrual syndrome. Maturitas. 2009;63:S114–S114.
- Machado DG, Bettio LEB, Cuhna MP, et al. Antidepressant-like effect of the extract of rosemarinus officinalis in mice: involvement of the monoaminergic system. Prog Neuro-Psychopharmacol Biol Psychiatry. 2009;33:642–650.
- Murphy PK, Wagner CL. Vitamin D and mood disorders among women: an integrative review. J Midwifery Womens Health. 2008;53: 440–446.
- Bertone-Johnson ER, Chocano-Bedoya PO, Zagarins SE, Micka AE, Ronnenberg AG. Dietary vitamin D3 levels and premenstrual syndrome in a college-aged population. J Steroid Biochem Mol Biol. 2010;121: 434–437.
- Epperson CN, Amin Z, Mason GF. Pathophysiology II: neuroimaging, GABA and the menstrual cycle. In: O’Brien PMS, Rapkin A, Schmidt P, editors. The Premenstrual Syndromes: PMS and PMDD. London: Informa Healthcare; 2007:99–107.
- Bastani F, Hashemi S. Effects of a web based lifestyle education on general health and severity of symptoms of premenstrual syndrome among female students: a randomised controlled trial. Social Behav Sci. 2012;46:3356–3362.
- Steiner M, Peer M, Macdougall M, Hasket R. The premenstrual tension syndrome rating scales: an updated version. J Affect Disord. 2011;135: 82–88.
- Budeiri DJ, Li Wan Po A, Dornan JC. Clinical trials of treatments of premenstrual syndrome: entry criteria and scales for measuring outcomes. Br J Obstet Gynaecol. 1994;101:689–695.
- Horney K. Die prämenstruellen Verstimmungen. [The Premenstrual upset]. Zeitschrift für Psychoanalytische Pädagogik. 1931;5:1–7.
- Frank RT. The hormonal basis of premenstrual tension. Arch Neurol Psychiatry. 1931;26:1053–1057.
- Horrobin DF, Manku MS. Premenstrual syndrome and premenstrual breast pain (cyclical mastalgia): disorders of essential fatty acid (EFA) metabolism. Prostaglandins Leukot Essent Fatty Acids. 1989;37; 255–261.